Elegen is a company that provides NGS verified, cell-free DNA synthesis with linear DNA from 1 to 7kb, offering high accuracy and fast delivery for synthetic biology workflows.

ELEGEN

Elegen

We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale.

To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges.

Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success. 

Sahsen Ventures

Alix Ventures

#TeamElegen welcomes @Tony Cox, Ph.D. as Principal Scientist! Tony brings extensive #synbio experience and a proven record of conceiving, developing and implementing innovative solutions on both an experimental and commercial high-throughput scale - a great fit for advancing ELEGEN's next-gen ENFINIA DNA scaleup development! #WelcometotheTeam, Tony!

#hiring #growing #BayAreaJobs #SanFrancisco #employeeappreciation

The RNA Therapeutics - From Concept to Clinic Conference is in full swing!  Stop by ELEGEN Booth 12 to learn about ENFINIA next-generation DNA - long, complex, clonal-quality DNA, shipped in 6-8 days and ready for direct use in your workflows, no cloning required. You can reliably count on ENFINIA DNA to meet your deadlines.

#RNAtherapeutics #nextgenDNA #EnfiniaDNA #mRNAvaccines RNA Therapeutics Institute at UMass Chan Medical School #RNATx

Join the team that is making next-gen DNA a reality! Our R&D and Operations groups continue to grow. Innovative technology, great culture, awesome people. Check out our open positions & apply: https://hubs.ly/Q02CP7vc0

#synbio  #biotech #SanFrancisco #BayAreaJobs #Hiring

Yesterday was International Women in Engineering Day, but we celebrate these women and the awesome skills they bring to #TeamElegen and #cellfreesynthesis every day! We ♥️ their knowledge, dedication, passion, and teamwork that enhance our products, technology, and work culture. 👏🎉

#INWED24 #EnhancedbyEngineering 
Marion Meunier, Nadiya Sitdykova, Iris HC Lin, Nidhi Gupta,
Radhika Dalal, Kellie King, Sukhvinder Kaur, Galit Meshulam-Simon

ENFINIA DNA is #NextGen DNA:
✅ Long (≤7 kb)
✅ NGS-verified
✅ High complexity
✅ ≥95% purity
✅ Reliable, fast turnaround (6-8 days)

With our cell-free DNA production tech, ENFINIA linear DNA ships ready-to-use with minimal or no cloning. 

ELEGEN's not your grandfather’s gene synthesis provider. 

Ready to get started? https://hubs.ly/Q02CvsCL0
#genesynthesis #EnfiniaDNA #cellfreesynthesis #DNAinnovation

This month’s #EmployeeSpotlight is on Kellie King, Sr. Research Associate. Working on the molecular biology team, she loves testing new ideas and streamlining processes to be as efficient as possible. We're #LuckytoHaveYou on #TeamElegen!👏🎉

Learn more about Kelly: https://bit.ly/3RBa0R3

#EmployeeAppreciation #BayAreaJobs

COM:ELEGENBIO

Elegen

name

homepage url

country

linkedin url

employee count

sector

industry

Description

investor of

Metrics